This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Implicit parasitic Sepsis, including avohilmo
AB1_SEPSIS_PARAS_IMPL_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditions
|
71805 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
255 |
4. Check minimum number of eventsNone |
255 |
5. Include endpointsNone |
255 |
6. Filter based on genotype QC (FinnGen only) |
224 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT
Extra metadata
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Implicit parasitic Sepsis, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Implicit Sepsis, including avohilmo
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 224 | 128 | 96 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 55.22 | 51.15 | 60.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 232
- Matched controls
- 2320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R55
ICD-10 Finland
Syncope and collapse
33.0
149.7
114
66
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
11.9
58.8
70
81
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
401.0
34.9
34
*
AA1AD
NOMESCO Finland
CT of head and brain
5.0
32.9
115
381
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.6
26.0
83
249
N17.9
ICD-10 Finland
Acute renal failure, unspecified
101.4
25.2
27
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
278.8
25.2
25
*
R51.80
ICD-10 Finland
Headache
4.2
21.2
75
239
P01AB01
ATC
metronidazole; oral, rectal
3.6
20.8
136
652
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
20.1
149
767
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
20.1
19
*
J01MA12
ATC
levofloxacin; systemic
3.8
17.8
71
243
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
182.6
16.7
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.4
16.4
78
298
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
16.0
65
224
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
15.5
116
575
R50.9
ICD-10 Finland
Fever, unspecified
3.7
15.4
59
195
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
15.3
62
213
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
15.1
93
412
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
14.7
50
152
C03CA01
ATC
furosemide; systemic
3.1
14.6
92
411
A06AC01
ATC
ispaghula (psylla seeds); oral
3.1
14.4
87
380
R42
ICD-10 Finland
Dizziness and giddiness
3.1
13.9
79
332
D64.9
ICD-10 Finland
Anaemia, unspecified
4.0
13.1
42
122
Z2221
NOMESCO Finland
Medical doctor
2.9
12.9
87
399
R06.0
ICD-10 Finland
Dyspnoea
2.8
12.8
91
429
D06
ICPC
Abdominal pain localized other
4.2
12.7
37
100
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
12.6
55
196
A41.9
ICD-10 Finland
Sepsis, unspecified
137.1
12.6
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
12.5
25
49
R53
ICD-10 Finland
Malaise and fatigue
2.8
12.5
86
398
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.1
12.3
62
241
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
12.3
70
292
N05BA01
ATC
diazepam; systemic, rectal
3.5
12.0
47
156
J01FF01
ATC
clindamycin; systemic
2.8
11.9
82
379
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
11.8
51
180
C03DA01
ATC
spironolactone; oral
3.7
11.8
43
136
A02BC05
ATC
esomeprazole; systemic
2.6
11.7
117
649
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.1
11.7
21
37
UJF30
NOMESCO Finland
Ileoscopy through colon
3.7
11.6
42
132
N03AX09
ATC
lamotrigine; oral
5.8
11.6
22
41
B54
ICD-10 Finland
Unspecified malaria
+∞
11.6
11
*
A59.0
ICD-10 Finland
Urogenital trichomoniasis
+∞
11.6
11
*
N30.0
ICD-10 Finland
Acute cystitis
3.2
11.5
55
207
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
11.5
41
128
A11
ICPC
Chest pain NOS
4.0
11.4
36
103
A04
ICPC
Weakness/tiredness general
3.1
11.3
57
221
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
11.3
54
203
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.4
11.1
30
76
XF404
NOMESCO Finland
Ambulatory ECG
4.1
11.1
33
90
E86
ICD-10 Finland
Volume depletion
12.8
11.1
19
16
R4110
NOMESCO Finland
Physiotherapy
2.7
11.0
87
428
N17
ICPC
Vertigo/dizziness
3.3
11.0
47
165
S06.0
ICD-10 Finland
Concussion
3.5
10.9
42
138
UJF32
NOMESCO Finland
Coloscopy
2.7
10.8
77
359
N06AX21
ATC
duloxetine; oral
3.4
10.8
43
144
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.1
10.7
32
88
A06.0
ICD-10 Finland
Acute amoebic dysentery
+∞
10.5
10
*
Z3226
NOMESCO Finland
Physiotherapist
2.9
10.5
62
262
N05CD07
ATC
temazepam; oral
3.4
10.4
41
136
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
10.4
45
159
J01MA06
ATC
norfloxacin; oral
3.2
10.3
46
165
XF402
NOMESCO Finland
ECG with work load test
3.6
10.3
38
121
Z71.8
ICD-10 Finland
Other specified counselling
2.5
10.2
104
573
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
10.2
75
354
W19
ICD-10 Finland
Unspecified fall
3.7
10.1
35
107
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
3.5
10.0
37
118
H02AB06
ATC
prednisolone; systemic
2.4
9.9
127
774
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
9.8
34
104
J96.1
ICD-10 Finland
Chronic respiratory failure
57.5
9.7
11
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.5
9.7
25
61
J01MA02
ATC
ciprofloxacin; systemic
2.4
9.7
107
609
A10AB05
ATC
insulin aspart; parenteral
4.1
9.7
28
75
D11
ICPC
Diarrhoea
3.1
9.6
46
172
N05CF01
ATC
zopiclone; oral
2.4
9.6
93
499
H02AB07
ATC
prednisone; oral
3.3
9.5
40
138
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.3
9.5
40
138
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
9.5
21
45
N05AH04
ATC
quetiapine; oral
2.8
9.5
57
242
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
+∞
9.4
9
*
1369X
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases
+∞
9.4
9
*
R5140
NOMESCO Finland
Monitoring the use of the aid
3.2
9.3
41
146
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
9.3
88
466
E0000UV, ,
ATC
2.3
9.2
117
703
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
9.2
82
422
I95.9
ICD-10 Finland
Hypotension, unspecified
25.2
9.0
12
5
L28
ICPC
Limited function/disability (L)
2.7
9.0
57
248
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
4.6
8.9
22
52
A28
ICPC
Limited function/disability NOS
2.8
8.9
54
230
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.3
8.8
24
61
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.9
8.7
27
76
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
8.6
35
118
N05CF02
ATC
zolpidem; oral
2.7
8.6
53
227
127
Kela drug reimbursment
Transplant complication
28.7
8.6
11
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.7
8.5
29
87
K59.1
ICD-10 Finland
Functional diarrhoea
4.1
8.5
24
63
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
8.5
57
255
N03AE01
ATC
clonazepam; systemic
4.4
8.5
22
54
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.8
8.4
27
78
M79.6
ICD-10 Finland
Pain in limb
2.2
8.4
119
741
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
8.4
60
277
R11
ICD-10 Finland
Nausea and vomiting
3.3
8.3
33
110
A06AD11
ATC
lactulose; oral
2.9
8.3
42
162
R06AE07
ATC
cetirizine; oral
2.2
8.0
117
732
H02AB04
ATC
methylprednisolone; systemic
2.8
8.0
45
183
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.3
8.0
21
52
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.0
98
572
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
8.0
54
242
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
7.9
33
113
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
6.8
7.9
19
30
N02AX02
ATC
tramadol; systemic, rectal
2.2
7.9
110
675
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
6.3
7.9
20
34
N06AX11
ATC
mirtazapine; oral
2.2
7.9
95
550
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.6
7.8
19
44
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.9
7.8
24
67
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
7.8
42
167
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.7
56
259
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.6
7.7
19
31
K59.09
ICD-10 Finland
Constipation, unspecified
3.6
7.6
26
78
Z50.1
ICD-10 Finland
Other physical therapy
4.5
7.6
19
45
C07AB07
ATC
bisoprolol; oral
2.1
7.5
125
817
Z2446
NOMESCO Finland
Social worker
3.6
7.5
26
79
A10AC01
ATC
insulin (human); parenteral
3.7
7.5
25
74
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
82.6
7.5
8
*
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
82.6
7.5
8
*
R03BA02
ATC
budesonide; inhalant
2.5
7.4
56
264
XW000
NOMESCO Finland
Bone marrow biopsy
4.6
7.4
18
42
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
7.3
7
*
A06.8
ICD-10 Finland
Amoebic infection of other sites
+∞
7.3
7
*
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
7.3
7
*
A07.2
ICD-10 Finland
Cryptosporidiosis
+∞
7.3
7
*
N03AX16
ATC
[U] pregabalin
2.4
7.3
62
308
B01AA03
ATC
warfarin; systemic
2.5
7.3
51
232
I50.9
ICD-10 Finland
Heart failure, unspecified
2.8
7.2
39
155
C07AG02
ATC
carvedilol; oral
3.9
7.2
22
61
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.9
7.2
22
61
A02BC01
ATC
omeprazole; systemic
2.3
7.2
73
391
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
20.8
7.2
10
5
L04AA01
ATC
[U] ciclosporin
20.8
7.2
10
5
R02
ICPC
Shortness of breath/dyspnoea
2.7
7.2
41
168
N02AA05
ATC
oxycodone; systemic
2.5
7.2
52
240
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
12.6
7.2
12
10
C07AB02
ATC
metoprolol; systemic
2.5
7.2
54
254
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
7.1
55
262
N06AA09
ATC
amitriptyline; systemic
3.1
7.1
32
115
R52.9
ICD-10 Finland
Pain, unspecified
2.9
7.0
35
133
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.9
7.0
36
139
JN4AD
NOMESCO Finland
Body CT examination
2.9
7.0
36
139
N05AX08
ATC
risperidone; systemic
3.1
6.9
31
111
J02AC01
ATC
fluconazole; systemic
2.1
6.9
101
624
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
6.9
76
421
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
6.8
31
112
A10AE04
ATC
insulin glargine; parenteral
3.1
6.8
29
101
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
2.1
6.7
138
962
H04.10
ICD-10 Finland
Dry eye syndrome
2.6
6.7
41
174
TAB00
NOMESCO Finland
Lumbar puncture
4.0
6.7
19
50
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.4
6.7
25
80
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.9
6.7
33
125
SPAT1229
SPAT
Assessment of need for aid
3.5
6.6
24
75
D06BB03
ATC
aciclovir; topical
4.2
6.6
18
46
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
6.5
55
271
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.7
6.5
38
157
R52.2
ICD-10 Finland
Other chronic pain
4.3
6.5
17
42
N03AG01
ATC
valproic acid; systemic, rectal
3.8
6.5
20
56
Z94.0
ICD-10 Finland
Kidney transplant status
71.7
6.5
7
*
L04AA06
ATC
mycophenolic acid; systemic
14.8
6.5
10
7
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
5.8
6.4
17
31
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
4.1
6.4
18
47
N06AB10
ATC
escitalopram; oral
2.3
6.4
55
274
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
6.3
68
371
SPAT1255
SPAT
Intravenous administration of medicine
3.7
6.3
20
57
A41.8
ICD-10 Finland
Other specified sepsis
+∞
6.3
6
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
6.3
6
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.1
6.3
16
28
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.3
6.2
24
78
I50.0
ICD-10 Finland
Congestive heart failure
3.5
6.2
22
68
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.8
6.2
19
53
A10AE05
ATC
insulin detemir; parenteral
3.8
6.2
19
53
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.8
6.2
19
53
N05BA04
ATC
oxazepam; oral
2.1
6.1
70
390
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.0
6.1
14
21
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.0
6.1
12
14
S22.3
ICD-10 Finland
Fracture of rib
3.3
6.1
24
79
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.3
6.1
51
250
Z3231
NOMESCO Finland
Registered nurse
2.1
6.1
76
439
XF600
NOMESCO Finland
Bloodpressure measurement
3.4
6.0
22
69
M01AE02
ATC
naproxen; oral, rectal
2.0
6.0
148
1083
A02BC02
ATC
pantoprazole; systemic
2.1
6.0
164
1245
H04AA01
ATC
glucagon; nasal, parenteral
7.6
6.0
13
18
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
5.3
6.0
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
71
79
12.51
61.50
3.1
1.6
—
—
—
0
0
88
232
5.50
33.21
9.2
3.9
1.10
1.02
mmol/l
1.34
82
209
55
113
6.07
26.90
2.3
1.5
—
—
—
0
0
38
62
7.13
23.18
1.6
1.6
1.13
5.57
ug/l
0.46
31
52
61
179
4.27
19.14
6.9
2.7
1.53
1.73
mmol/l
0.16
56
155
30
52
6.48
17.13
1.7
1.4
—
—
—
0
0
85
337
3.40
16.91
4.2
3.4
407.53
340.20
ng/l
0.10
66
256
173
1045
3.58
16.78
10.2
5.9
10.45
11.42
umol/l
0.74
167
990
165
976
3.39
16.41
14.7
5.8
1.21
1.21
mmol/l
0.34
151
837
154
879
3.24
16.20
12.3
5.0
1.20
1.22
mmol/l
1.18
146
805
74
277
3.45
16.04
3.1
1.8
—
—
—
0
0
115
566
3.05
15.57
5.2
2.9
0.22
0.31
e6/l
0.52
81
402
60
200
3.70
15.49
2.9
1.7
—
—
—
0
0
58
189
3.76
15.48
3.0
1.8
—
—
—
0
0
120
610
3.00
15.25
3.5
2.1
56.09
73.11
u/l
0.94
106
559
74
285
3.34
15.23
3.9
2.1
2.20
2.33
g/l
0.93
67
262
133
716
3.01
15.20
5.3
2.9
—
—
—
0
0
147
841
3.04
14.95
8.3
4.0
34.32
36.18
g/l
3.04
140
796
77
314
3.17
14.31
3.9
2.2
10.68
13.46
umol/l
2.30
71
289
176
1159
3.15
13.07
9.9
4.0
6.82
6.59
mmol/l
0.60
167
1091
113
600
2.72
12.60
2.2
1.7
16.97
21.44
nmol/l
3.00
97
492
74
315
2.98
12.56
4.5
2.8
3.79
2.09
e6/l
0.40
32
151
78
342
2.93
12.55
4.5
2.7
0.98
0.88
e6/l
0.10
38
177
207
1519
4.37
12.54
13.0
7.3
74.06
78.17
u/l
1.09
198
1420
34
87
4.41
12.51
2.4
1.7
—
—
—
0
0
19
12
17.11
12.37
2.2
1.2
—
—
—
0
0
19
13
15.79
12.02
2.2
1.3
—
—
—
0
0
54
198
3.25
11.78
13.0
6.0
0.75
0.75
mmol/l
0.00
44
169
144
890
2.63
11.42
2.9
2.1
99.53
95.32
pmol/l
0.48
82
447
143
895
2.56
10.82
3.3
2.4
77.84
76.84
nmol/l
0.17
134
787
44
151
3.36
10.62
4.0
2.6
64.58
67.18
g/l
1.64
39
145
149
959
2.55
10.49
4.9
2.9
106.62
105.66
ug/l
0.02
140
897
114
650
2.48
10.45
5.0
2.9
28.97
29.79
u/l
0.16
109
619
20
39
5.52
10.03
2.7
1.5
—
—
—
0
0
96
514
2.48
10.00
1.6
1.3
1.04
1.42
u/ml
0.24
18
137
96
515
2.47
9.94
3.2
1.9
2.54
2.86
mg/l
0.85
88
441
34
103
3.70
9.89
1.8
1.3
—
—
—
0
0
24
56
4.66
9.84
1.9
1.3
287.37
318.63
ug/g
0.30
16
37
24
56
4.66
9.84
1.5
1.2
—
—
—
0
0
85
434
2.51
9.76
2.7
1.7
1.35
1.17
mg/l
0.20
72
340
69
319
2.66
9.73
2.0
1.6
954.41
1175.47
nmol/l
1.44
51
235
25
61
4.47
9.71
1.5
1.1
—
—
—
0
0
52
210
2.90
9.47
2.9
2.6
7.54
5.98
umol/l
0.49
44
186
38
128
3.35
9.41
5.1
3.0
94.54
77.53
ng/l
0.63
28
111
47
181
3.00
9.31
3.2
2.1
34.24
32.11
u/l
0.21
42
150
20
42
5.12
9.25
2.8
1.5
—
—
—
0
0
89
476
2.41
9.14
4.3
2.8
342.69
331.74
umol/l
0.44
75
415
34
109
3.48
9.08
7.5
2.4
1.80
1.72
mmol/l
0.04
26
86
24
60
4.35
9.04
1.5
1.2
—
—
—
0
0
104
600
2.33
8.93
4.4
3.1
1375.10
1164.71
ng/l
0.36
92
504
33
106
3.46
8.78
5.0
2.3
130.48
128.76
g/l
0.14
33
101
165
1167
2.43
8.66
14.5
9.6
4.19
4.01
e9/l
0.38
145
1031
120
754
2.23
8.21
5.5
3.7
39.79
42.98
ng/l
0.08
90
528
21
51
4.43
8.19
2.2
4.0
1.30
2.89
ratio
0.69
11
26
16
19
8.95
7.95
2.1
1.9
—
—
—
0
0
194
1505
2.76
7.92
6.6
4.1
16.15
11.06
mm/h
2.78
183
1384
57
264
2.54
7.85
14.2
5.4
104.33
104.30
mmol/l
0.02
57
264
16
20
8.50
7.73
2.1
1.8
—
—
—
0
0
16
20
8.50
7.73
2.1
1.8
—
—
—
0
0
166
1213
2.30
7.53
4.1
3.0
—
—
—
0
0
174
1299
2.36
7.47
5.0
3.1
54.55
41.99
u/l
0.71
164
1224
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
34
5.99
7.24
4.1
2.0
0.37
0.32
iu/ml
—
9
16
15
19
8.36
7.22
2.1
1.9
—
—
—
0
0
15
19
8.36
7.22
2.3
1.5
—
—
—
0
0
15
20
7.94
7.02
2.1
1.8
—
—
—
0
0
15
20
7.94
7.02
2.1
1.8
—
—
—
0
0
15
20
7.94
7.02
2.7
1.4
—
—
—
0
0
29
99
3.20
6.98
2.4
2.2
1.13
1.20
%
0.17
29
99
16
24
7.08
6.94
2.8
1.9
—
—
—
0
0
21
58
3.88
6.92
2.4
4.2
113.98
28.20
mg/l
0.56
21
51
21
58
3.88
6.92
2.4
4.2
51.40
140.24
mg/l
0.43
21
51
44
191
2.61
6.87
2.4
1.9
346.65
377.99
nmol/l
0.50
37
179
111
713
2.07
6.80
4.4
3.0
2.32
2.36
mmol/l
2.25
104
641
149
1070
2.10
6.69
6.3
3.7
0.00
0.00
estimate
-0.00
33
233
12
12
10.47
6.61
1.5
1.3
—
—
—
0
0
49
228
2.46
6.61
1.9
1.6
1.60
1.40
%
0.89
41
194
151
1094
2.09
6.56
6.3
3.8
0.00
0.02
estimate
0.50
31
216
10
7
14.85
6.45
1.4
1.7
—
—
—
0
0
10
7
14.85
6.45
1.4
1.7
—
—
—
0
0
149
1080
2.06
6.39
6.3
3.7
0.00
6.88
estimate
0.50
33
236
14
20
7.37
6.32
2.1
1.5
—
—
—
0
0
31
118
2.88
6.19
1.0
1.0
—
—
—
0
0
25
88
3.06
5.72
1.6
1.4
—
—
—
0
0
189
1528
2.28
5.71
5.5
4.3
14.69
14.79
pmol/l
0.21
174
1376
79
478
1.99
5.47
3.9
2.3
—
—
—
0
0
20
64
3.33
5.33
6.0
1.9
24.25
25.07
mmol/l
0.35
20
64
5
0
+∞
5.22
4.6
0.0
—
—
—
0
0
8
6
13.74
5.11
1.5
1.8
—
—
—
0
0
8
6
13.74
5.11
1.5
1.8
—
—
—
0
0
15
33
4.79
4.96
2.3
1.5
—
—
—
0
0
19
62
3.25
4.91
3.3
2.7
—
—
—
0
0
18
57
3.34
4.88
1.3
1.3
—
—
—
0
0
66
391
1.96
4.77
2.0
1.7
483.79
36449022.05
pmol/l
0.50
58
321
211
1830
2.69
4.76
7.3
5.3
1.94
1.93
mu/l
0.06
201
1656
34
155
2.40
4.75
2.6
2.4
9.48
6.49
ug/l
0.56
29
132
18
58
3.28
4.75
9.6
2.4
8.83
8.50
kpa
0.31
18
58
9
11
8.46
4.60
2.3
1.5
—
—
—
0
0
220
1961
3.36
4.47
37.0
13.3
24.94
22.47
mg/l
0.54
191
1582
15
38
4.15
4.39
2.0
1.3
—
—
—
0
0
14
34
4.31
4.29
1.8
1.2
438.57
305.91
u/ml
—
7
11
13
30
4.53
4.20
2.4
1.5
—
—
—
0
0
68
424
1.85
4.15
3.2
2.7
2.42
2.45
mmol/l
1.59
63
382
8
10
8.24
4.09
1.6
1.8
16.88
11.60
u/l
—
8
10
123
921
1.71
3.95
4.7
2.6
—
—
estimate
—
0
0
7
8
8.97
3.80
1.0
1.3
—
—
—
0
0
17
61
2.93
3.78
1.5
1.3
—
—
—
0
0
14
39
3.75
3.77
3.3
2.4
15.29
16.17
%
0.44
14
39
18
67
2.83
3.75
1.3
2.8
0.00
0.00
g/l
-0.00
18
59
14
45
3.25
3.71
5.4
2.9
0.56
2.00
index
—
9
29
14
40
3.66
3.68
2.1
1.3
—
—
—
0
0
10
21
4.93
3.60
2.3
1.6
—
—
—
0
0
9
17
5.46
3.54
1.0
1.2
—
—
—
0
0
26
120
2.31
3.54
21.0
7.4
0.60
0.66
%
0.37
26
120
60
377
1.80
3.52
1.2
1.3
29.00
30.41
iu/ml
—
8
116
13
42
3.22
3.42
3.5
2.5
7.55
6.62
pmol/l
0.28
13
42
6
7
8.76
3.28
3.3
1.6
—
—
—
0
0
26
125
2.22
3.23
20.9
7.2
1.39
1.38
%
0.02
26
125
10
25
4.13
3.12
3.4
5.1
—
—
—
0
0
8
16
5.14
3.08
2.8
1.4
0.61
0.63
e9/l
—
8
16
6
8
7.66
3.07
2.5
3.5
0.63
0.61
mmol/l
—
6
8
6
8
7.66
3.07
2.3
1.6
—
—
—
0
0
6
8
7.66
3.07
2.3
1.5
—
—
—
0
0
6
8
7.66
3.07
2.3
1.5
—
—
—
0
0
14
52
2.80
2.94
1.4
1.4
0.14
0.23
iu/ml
—
5
12
37
212
1.89
2.89
3.6
2.4
—
—
—
0
0
13
47
2.87
2.86
7.2
2.0
—
—
—
0
0
8
18
4.56
2.82
3.5
2.1
—
—
—
0
0
8
18
4.56
2.82
1.0
1.2
—
—
—
0
0
10
28
3.68
2.82
2.3
1.6
—
—
—
0
0
5
6
8.48
2.76
1.2
1.5
—
—
—
0
0
88
649
1.57
2.73
5.5
3.8
12.79
8.10
mg/mmol
0.52
62
397
12
43
2.89
2.69
2.8
2.4
34.71
146.47
ug/min
—
7
25
83
606
1.58
2.69
6.2
3.9
0.00
0.00
estimate
-0.00
33
211
15
61
2.56
2.68
3.0
1.7
—
—
—
0
0
7
15
4.78
2.61
1.0
1.1
—
—
—
0
0
7
15
4.78
2.61
3.9
2.3
—
—
—
0
0
208
1890
1.97
2.60
32.2
13.8
79.33
81.90
ml/min/173m2
0.81
189
1732
5
7
7.27
2.56
2.6
2.0
—
—
—
0
0
51
335
1.67
2.51
1.2
1.3
2.39
14.07
u/ml
2.18
15
136
6
12
5.10
2.41
1.8
1.8
75.00
102.25
%
—
6
12
6
12
5.10
2.41
1.0
1.0
—
—
—
0
0
6
12
5.10
2.41
1.2
3.3
58.67
224.75
nmol/l
—
6
12
6
12
5.10
2.41
1.7
1.3
10.67
9.83
u/l
—
6
12
22
112
2.07
2.40
4.1
2.1
—
—
—
0
0
203
1843
1.81
2.36
8.4
6.3
39.98
38.97
mmol/mol
0.76
194
1727
25
135
1.95
2.33
4.2
2.1
—
—
—
0
0
19
93
2.14
2.29
1.6
1.7
6.90
6.33
iu/ml
—
6
21
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
9
5.65
2.22
1.0
1.3
—
—
—
0
0
5
9
5.65
2.22
5.6
5.7
776.80
907.89
u/ml
—
5
9
6
14
4.37
2.16
2.3
1.5
—
—
—
0
0
37
233
1.70
2.13
3.9
2.4
—
—
—
0
0
105
840
1.46
2.10
6.7
3.5
0.00
0.00
estimate
0.50
28
204
9
31
2.98
2.09
1.2
1.1
—
—
—
0
0
7
20
3.57
2.07
12.4
10.0
6.91
5.88
mmol/l
—
7
14
8
26
3.15
2.03
1.3
1.1
—
—
—
0
0
10
38
2.70
2.03
2.5
1.4
—
—
—
0
0
9
32
2.88
2.02
1.2
1.4
—
—
—
0
0
9
32
2.88
2.02
1.2
1.4
—
—
—
0
0
80
611
1.47
2.01
5.9
3.1
0.00
0.01
estimate
0.50
30
191
220
2070
2.21
1.99
43.7
17.9
85.22
75.23
umol/l
2.39
220
2040
65
477
1.50
1.98
5.3
3.7
1.02
1.02
kg/l
0.21
47
303
14
65
2.23
1.92
2.7
1.8
—
—
—
0
0
16
79
2.10
1.90
2.0
1.7
4.98
7.09
u/ml
—
5
16
218
2052
2.03
1.84
20.3
11.2
26.20
25.17
u/l
0.18
212
1990
55
398
1.50
1.79
1.9
1.6
—
—
—
0
0
31
196
1.67
1.77
7.6
3.0
—
—
—
0
0
8
30
2.72
1.74
1.1
1.6
—
—
—
0
0
5
13
3.90
1.72
3.6
1.6
—
—
—
0
0
198
1823
1.59
1.71
5.0
4.3
1.33
1.27
mmol/l
0.54
182
1667
205
1905
1.65
1.68
6.1
5.0
6.12
5.88
mmol/l
1.30
189
1741
6
19
3.21
1.67
2.2
2.3
1.25
1.20
mmol/l
—
6
19
6
19
3.21
1.67
2.2
2.3
108.33
105.42
mmol/l
—
6
19
7
25
2.85
1.66
1.3
1.2
—
—
—
0
0
5
14
3.63
1.62
1.6
1.0
—
—
—
0
0
5
14
3.63
1.62
1.2
1.0
—
—
—
0
0
7
28
2.55
1.46
1.0
1.3
—
—
—
0
0
7
28
2.55
1.46
1.0
1.1
—
3.73
—
0
6
5
16
3.17
1.44
1.6
1.9
—
—
—
0
0
5
16
3.17
1.44
1.6
1.9
—
—
—
0
0
5
16
3.17
1.44
1.6
1.9
—
—
—
0
0
5
16
3.17
1.44
1.8
1.4
271.80
282.29
u/l
—
5
16
6
22
2.77
1.44
1.5
1.2
—
—
—
0
0
7
29
2.46
1.40
1.0
1.2
—
—
—
0
0
6
23
2.65
1.37
1.3
1.3
—
—
—
0
0
6
23
2.65
1.37
1.0
1.3
—
—
—
0
0
5
17
2.98
1.36
1.0
1.1
—
—
—
0
0
207
1949
1.58
1.34
6.9
5.9
2.55
2.70
mmol/l
1.85
198
1798
6
24
2.54
1.31
1.7
1.4
—
—
nmol/l
—
0
0
6
24
2.54
1.31
1.2
1.1
—
—
—
0
0
5
18
2.82
1.29
2.6
1.4
—
—
—
0
0
6
25
2.44
1.25
1.0
1.3
—
—
—
0
0
6
25
2.44
1.25
1.0
1.3
—
—
—
0
0
6
25
2.44
1.25
1.0
1.3
—
—
—
0
0
203
1915
1.48
1.17
6.0
5.2
4.36
4.63
mmol/l
3.02
190
1778
202
1907
1.46
1.12
5.8
5.1
1.40
1.48
mmol/l
1.79
187
1756
5
21
2.41
1.09
1.2
1.0
—
—
—
0
0
5
21
2.41
1.09
1.8
1.4
0.18
0.16
nmol/l
—
5
10
98
853
1.26
0.94
2.2
1.9
1.36
1.36
mmol/l
0.01
81
706
6
29
2.10
0.90
1.7
1.4
—
—
—
0
0
8
46
1.77
0.83
1.1
1.3
—
—
—
0
0
11
66
1.70
0.80
1.4
2.1
—
—
—
0
0
6
33
1.84
0.79
2.5
1.3
0.29
0.32
nmol/l
—
6
23
7
46
1.54
0.48
2.0
1.5
—
—
—
0
0
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
42
381
1.12
0.24
2.7
3.4
0.57
0.75
ug/l
1.11
32
251
0
12
0.00
0.21
0.0
1.2
—
80.01
—
0
12
0
12
0.00
0.21
0.0
1.2
—
28.97
—
0
12
0
12
0.00
0.21
0.0
1.3
—
198.98
—
0
12
55
512
1.10
0.20
3.5
5.0
23.17
21.52
%
0.19
18
258
18
157
1.16
0.18
2.7
2.8
50.50
63.12
ml/min/173m2
—
10
58
28
258
1.10
0.13
4.5
4.7
29.50
31.34
%
0.47
22
155
25
237
1.06
0.06
15.3
6.7
—
—
—
0
0
16
167
0.95
0.01
1.7
1.4
—
—
—
0
0
5
59
0.84
-0.00
1.4
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
7.76
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
96.60
—
0
5
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
30
300
1.00
-0.00
1.7
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_SEPSIS_PARAS_IMPL_WIDE – Implicit parasitic Sepsis, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).